Publication
Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo.


AuthorsRiemenschneider H, Simonetti F*, Sheth U*, Katona E*, Roth S, Hutten S, Farny D, Michaelsen M, Nuscher B, Schmidt MK, Flatley A, Schepers A, Gruijs da Silva LA, Zhou Q, Klopstock T, Liesz A, Arzberger T, Herms J, Feederle R, Gendron TF, Dormann D and Edbauer D  (*indicates joint contribution) 
Group Leader Dormann
JournalActa Neuropathol Commun
Citation page numbers11:112
DateJul 2023
PubMedID37434215
Publication URLhttps://doi.org/10.1186/s40478-023-01592-z